
|Articles|March 10, 2008
Latebreakers: Dual anti-cholesterol niacin/statin combo granted approval
NiaSpan and simvastatin combination approved for cholesterol lowering.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Wicked Good Cardiometabolic Chat: Identifying and Managing MASH
2
Study Links Antipsychotic Use to Rapid Rise in Youth Type 2 Diabetes
3
Optimizing MTM Services for Patients With Cardiometabolic Conditions: A Practical Guide for Pharmacists
4
Experts Uncertain of GLP-1s’ Long-Term Clinical Benefits
5






















